RFG Advisory LLC Acquires 2,175 Shares of Intuitive Surgical, Inc. $ISRG

RFG Advisory LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 42.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,345 shares of the medical equipment provider’s stock after acquiring an additional 2,175 shares during the quarter. RFG Advisory LLC’s holdings in Intuitive Surgical were worth $2,921,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Main Street Group LTD bought a new position in Intuitive Surgical in the 1st quarter valued at $30,000. Compass Financial Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $30,000. Vermillion Wealth Management Inc. raised its stake in shares of Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares during the period. Motiv8 Investments LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $34,000. Finally, Evergreen Advisors LLC purchased a new position in shares of Intuitive Surgical in the 1st quarter worth about $35,000. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary Guthart sold 10,000 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the sale, the director owned 1,245,679 shares of the company’s stock, valued at $498,271,600. The trade was a 0.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 400 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director owned 251 shares in the company, valued at approximately $95,129. This represents a 61.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 11,256 shares of company stock valued at $4,475,079 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on ISRG. The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a research report on Wednesday, May 27th. Wall Street Zen cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. Stifel Nicolaus reduced their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Bank of America decreased their price target on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Stock Up 2.0%

NASDAQ ISRG opened at $360.46 on Friday. The company has a market cap of $127.34 billion, a PE ratio of 41.29, a price-to-earnings-growth ratio of 2.67 and a beta of 1.47. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The firm’s 50-day simple moving average is $377.41 and its two-hundred day simple moving average is $424.21.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter last year, the company earned $1.81 earnings per share. The company’s revenue was up 18.4% on a year-over-year basis. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.85 EPS for the current year.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: A meta-analysis found that da Vinci robotic-assisted surgery produced statistically significant improvements across 13 common benign conditions, including shorter hospital stays and faster returns to work versus laparoscopic and open surgery. The results reinforce the clinical value of Intuitive’s platform and could support further hospital adoption. Intuitive reports positive meta-analysis data
• Positive Sentiment: BTIG reiterated its Buy rating and set a $469 price target, signaling considerable potential upside. Broader analyst coverage remains favorable, with the stock described as trading at its cheapest valuation in roughly a decade. Recent earnings also showed strong execution, including 18.4% year-over-year revenue growth and an earnings beat. BTIG reiterates Buy rating
• Neutral Sentiment: Intuitive Surgical presented at the Wells Fargo Healthcare Conference. Investors are focused on management’s commentary regarding procedure trends, guidance, competition, costs and the long-term opportunity for robotic surgery. Wells Fargo Healthcare Conference transcript
• Neutral Sentiment: Reported short-interest data showed zero shares and a zero-day short-interest ratio, suggesting no measurable short positioning in the supplied data; however, the figures appear anomalous and should not be treated as a meaningful trading signal.
• Negative Sentiment: EVP Mark Brosius disclosed sales totaling 69 shares at approximately $350.20 and $361.23 under a pre-arranged Rule 10b5-1 plan. The transactions are small relative to his remaining holdings and are not necessarily bearish, but continued insider selling provides little additional support for the shares. Intuitive Surgical EVP stock sale
• Negative Sentiment: Investors remain concerned about slower U.S. procedure growth, rising costs, competitive pressure and the possibility that GLP-1 drugs could affect procedure volumes. Options markets also indicate that substantial volatility may persist after the stock’s steep decline from its 52-week high. ISRG volatility outlook

About Intuitive Surgical

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.